BioRN Annual Conference 2024

Meet Quality Assistance at BioRN Annual Conference

Our Key Account Managers, Jordan Cossu and Cécile Montagne, will be participating to the BioRN Annual Conference about New Therapeutic Modalities in Personalised Medicine. Thanks to groundbreaking technological advancements, radiopharmaceuticals and antibody drug conjugates have once more opened up remarkable capabilities towards clinical development. In addition, new insights in epigenetics, RNA biology, and molecular glues have unveiled avenues for other novel therapeutic modalities holding great promise for individual treatments. The BioRN Annual Conference will bring together expertise in basic, applied and clinical research in these fields, fostering new perspectives and visions for personalised medicine. 

Biotherapeutics Expertise

To accelerate the development and marketing of your Biotherapeutics, Quality Assistance offers a complete analytical package to meet the EMA and FDA requirements, all on one site. Whether it is to extend your analytical capacities or to outsource parts or all of your analytical needs, our experts teams are here to support your developments of mAbs, ADCs and biotherapeutics.

mRNA Expertise

mRNA is a new class of therapeutics designed to instruct patients’ own cells to produce a protein that can treat, cure or prevent diseases. mRNA therapeutics are being developed as vaccines against infectious diseases, as cancer immunotherapy, and as protein replacement therapy for rare diseases.

Building on its considerable experience in the analysis of complex innovative drugs, Quality Assistance is continuously advancing ways to support the development of your mRNA-based therapeutics and expanding its related machinery and equipment.

Don't hesitate to come and meet our team at the BioRN Annual Conference to discuss your outsourcing needs. 

ABOUT THE EVENT

Visit https://www.biorn.org/biorn-annual-conference for more information